Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $64.98M.
ENTERPRISE VALUE (EV)
$64.98M
Aardvark Therapeutics, Inc. Common Stock
Market Cap
$112.03M
Enterprise Value (EV)
$64.98M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Aardvark Therapeutics, Inc. Common Stock (AARD) | $112.03M | $64.98M |
| BGM Group Ltd. (BGM)vs › | $111.21M | $100.86M |
| Apyx Medical Corporation (APYX)vs › | $110.33M | $122.34M |
| Immunic, Inc. (IMUX)vs › | $109.55M | N/A |
| Insight Molecular Diagnostics Inc. (IMDX)vs › | $109.46M | $94.33M |
| Outlook Therapeutics, Inc. (OTLK)vs › | $109.08M | $116.26M |
| MaxCyte, Inc. (MXCT)vs › | $113.01M | $115.22M |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $108.59M | $106.36M |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs › | $107.68M | $88.57M |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $107.28M | $108.13M |
Market Cap
$112.03M
Total Debt
$0.00
Cash
$47.05M
Enterprise Value
$64.98M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
